GlenRock Israel

Type

Private equity

Status

Active

Location

Israel, Herzliya

Total investments

35

Average round size

9M

Portfolio companies

22

Rounds per year

1.75

Follow on index

0.37

Exits

5

Stages of investment
SeedPrivate EquityLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareManufacturingMedical DeviceCyber SecurityDigital MarketingAdvertisingContent DiscoveryContent Marketing

Summary

In 2003 was created GlenRock Israel, which is appeared as VC.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the GlenRock Israel, startups are often financed by Lightspeed Venture Partners, Viola Ventures, Steamboat Ventures. The meaningful sponsors for the fund in investment in the same round are Lightspeed Venture Partners, Gemini Israel Ventures, Viola Ventures. In the next rounds fund is usually obtained by Lightspeed Venture Partners, Viola Ventures, Gemini Israel Ventures.

Among the most successful fund investment fields, there are Network Security, Enterprise Software. Among the various public portfolio startups of the fund, we may underline Mobileye, LifeBond Ltd., Ecoppia The fund has exact preference in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Besides them, we counted 4 critical employees of this fund in our database.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014. Considering the real fund results, this VC is 15 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this GlenRock Israel performs on 19 percentage points less the average number of lead investments. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. When the investment is from GlenRock Israel the average startup value is 100-500 millions dollars.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesMedtechCannabisHealthcareManufacturing
Stage focus
GeneralistPre-SeedSeedSeries ASeries B Show 1 more
Geo focus
Israel

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
35
Lead investments
0
Exits
5
Rounds per year
1.75
Follow on index
0.37
Investments by industry
  • Software (8)
  • Cyber Security (7)
  • Medical Device (6)
  • Advertising (6)
  • Biotechnology (5)
  • Show 55 more
Investments by region
  • Israel (21)
  • United States (12)
Peak activity year
2007

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
53M
Group Appearance index
0.94
Avg. company exit year
12
Avg. multiplicator
3.79
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CyberX 01 Aug 2016 Cyber Security, Network Security, Security, Industrial Early Stage Venture 9M United States, Massachusetts
Nurami Medical 02 Nov 2020 Health Care, Medical Device, Nanotechnology Early Stage Venture 6M North District, Nazareth, Israel

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.